Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM/C2 cell lines after treatment with doxorubicin. [electronic resource]
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Sep 2004
- 295-302 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
1570-0232
10.1016/j.jchromb.2004.05.017 doi
Antineoplastic Agents--pharmacology Cell Line Doxorubicin--pharmacology Reference Standards Subcellular Fractions--metabolism